PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department Medical Sciences, Infectious Diseases and Dermatology Section, University of Ferrara, Italy. Electronic address: carlo.contini@unife.it.\', \'Dept. Morphology, Surgery, Exp. Medicine, PhDs Molecular Medicine, University of Ferrara, Italy.\', \'ENT, Dept Neuroscience, Imaging & Clinical Sciences, G d\'Annunzio University, Chieti, Italy.\', \'Molecular Immunopharmacology & Drug Discovery Lab, Tufts University, Boston, MA 02111, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0306-9877(20)30951-810.1016/j.mehy.2020.109876
?:hasPublicationType
?:journal
  • Medical hypotheses
is ?:pmid of
?:pmid
?:pmid
  • 32562915
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.443
?:rankingScore_hIndex
  • 75
is ?:relation_isRelatedTo_publication of
?:title
  • A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all